SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY
January 30 2024 - 4:01PM
SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT; “SINTX” or
the “Company”), a manufacturer and developer of advanced ceramic
materials and related technologies, announced that its wholly owned
subsidiary Technology Assessment & Transfer, Inc. (TA&T)
has entered into a Cooperative Research and Development Agreement
(CRADA) with the U.S. Army Combat Capabilities Development Command
Army Research Laboratory (DEVCOM ARL). This partnership is expected
to leverage the strengths of both organizations in the areas of
ceramic additive manufacturing (ceramic 3D printing) and ceramic
matrix composites (CMCs).
According to its website, the U.S. Army DEVCOM
Army Research Laboratory is the U.S. Army’s research laboratory
strategically placed under the Army Futures Command. DEVCOM ARL is
the Army’s sole foundational research laboratory focused on
cutting-edge scientific discovery, technological innovation, and
transitioning capabilities for the future Army (See:
(https://arl.devcom.army.mil/).
SINTX’s Millersville, MD facility, Technology
Assessment and Transfer, Inc., began work on ceramic 3D printing in
the mid 1990’s, printing its first component in 1998. SINTX now
provides prototype and Low-Rate Initial Production (LRIP) ceramic
3D printing services, sells ceramic-filled resins that customers
use in their own printing processes, and works with multiple
customers in the development of printing solutions for new
materials.
In parallel to ceramic 3D printing, SINTX’s
Maryland site has also been developing ultra-high temperature CMCs,
and building extensive capabilities in the densification of
fiber-based preforms using both chemical vapor infiltration and
polymer infiltration and pyrolysis. SINTX is excited to
participate in the dramatic increase in the market need for these
materials in hypersonic vehicle applications as one example.
Ann Kutsch, General Manager of the Maryland
site, commented: “We have a highly skilled team of engineers and
technicians here in Maryland, all of whom are instrumental in
pushing this cutting-edge work forward. I look forward to
optimizing our offerings in these markets while also working with
DEVCOM ARL to build both teams’ knowledge and capabilities in
advanced technologies.”
###
About SINTX Technologies, Inc.
SINTX Technologies is an advanced ceramics
company that develops and commercializes materials, components, and
technologies for medical and technical applications. SINTX is a
global leader in the research, development, and manufacturing of
silicon nitride, and its products have been implanted in humans
since 2008. Over the past several years, SINTX has utilized
strategic acquisitions and alliances to enter into new markets. The
Company has manufacturing and R&D facilities in Utah and
Maryland.
For more information on SINTX Technologies or its materials
platform, visit www.sintx.com.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 (PSLRA), including, but not limited to,
statements regarding SINTX’s ability to effectively develop a range
of innovative applications of our ceramic additive manufacturing
capabilities, SINTX’s ability to commercialize its technologies and
broaden the applications that benefit from such technologies, and
other statements that are not based on historical fact. Such
forward-looking statements are subject to a number of risks and
uncertainties that may cause actual results to differ from current
expectations. Risks and uncertainties that may cause such
differences include, among other things: SINTX’s products may not
prove to be as effective as other products currently being
commercialized or to be commercialized in the future by
competitors; risks inherent in manufacturing and scaling up to
commercial quantities while maintaining quality controls and
qualification standards; the uncertainties inherent in new product
development, including the cost and time required to commercialize
such product(s); market acceptance of SINTX’s products once
commercialized; risks related to manufacturing products and market
acceptance volatility in the price of SINTX’s common stock; SINTX’s
ability to raise funding and other competitive developments.
Readers are cautioned not to place undue reliance on the
forward-looking statements, which speak only as of the date on
which they are made and reflect management’s current estimates,
projections, expectations and beliefs. There can be no assurance
that any of the anticipated results will occur on a timely basis or
at all due to certain risks and uncertainties, a discussion of
which can be found in SINTX’s Risk Factors disclosure in its Annual
Report on Form 10-K, filed with the Securities and Exchange
Commission (SEC) on March 29, 2023, and in SINTX’s other filings
with the SEC. SINTX disclaims any obligation to update any
forward-looking statements. SINTX undertakes no obligation to
publicly revise or update the forward-looking statements to reflect
events or circumstances that arise after the date of this
report.
Business and Media Inquiries for SINTX:SINTX
Technologies801.839.3502IR@sintx.com
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Jun 2024 to Jul 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Jul 2023 to Jul 2024